|
1
|
Sanger HL, Klotz G, Riesner D, Gross HJ
and Kleinschmidt AK: Viroids are single-stranded covalently closed
circular RNA molecules existing as highly base-paired rod-like
structures. Proc Natl Acad Sci USA. 73:3852–3856. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen LL: The biogenesis and emerging roles
of circular RNAs. Nat Rev Mol Cell Biol. 17:205–211. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han B, Chao J and Yao H: Circular RNA and
its mechanisms in disease: From the bench to the clinic. Pharmacol
Ther. 187:31–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Enuka Y, Lauriola M, Feldman ME, Sas-Chen
A, Ulitsky I and Yarden Y: Circular RNAs are long-lived and display
only minimal early alterations in response to a growth factor.
Nucleic Acids Res. 44:1370–1383. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jeck WR and Sharpless NE: Detecting and
characterizing circular RNAs. Nat Biotechnol. 32:453–461. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bachmayr-Heyda A, Reiner AT, Auer K,
Sukhbaatar N, Aust S, Bachleitner-Hofmann T, Mesteri I, Grunt TW,
Zeillinger R and Pils D: Correlation of circular RNA abundance with
proliferation-exemplified with colorectal and ovarian cancer,
idiopathic lung fibrosis, and normal human tissues. Sci Rep.
5:80572015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kramer MC, Liang D, Tatomer DC, Gold B,
March ZM, Cherry S and Wilusz JE: Combinatorial control of
drosophila circular RNA expression by intronic repeats, hnRNPs, and
SR proteins. Genes Dev. 29:2168–2182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Conn SJ, Pillman KA, Toubia J, Conn VM,
Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA and
Goodall GJ: The RNA binding protein quaking regulates formation of
circRNAs. Cell. 160:1125–1134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Zhang XO, Chen T, Xiang JF, Yin
QF, Xing YH, Zhu S, Yang L and Chen LL: Circular intronic long
noncoding RNAs. Mol Cell. 51:792–806. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suzuki H, Zuo Y, Wang J, Zhang MQ,
Malhotra A and Mayeda A: Characterization of RNase R-digested
cellular RNA source that consists of lariat and circular RNAs from
pre-mRNA splicing. Nucleic Acids Res. 34:e632006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng S, Gu T, Bao X, Sun J, Zhao J, Zhang
T and Zhang L: Circular RNA hsa_circ_0014243 may serve as a
diagnostic biomarker for essential hypertension. Exp Ther Med.
17:1728–1736. 2019.PubMed/NCBI
|
|
13
|
Ye YL, Yin J, Hu T, Zhang LP, Wu LY and
Pang Z: Increased circulating circular RNA_103516 is a novel
biomarker for inflammatory bowel disease in adult patients. World J
Gastroenterol. 25:6273–6288. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lei B, Tian Z, Fan W and Ni B: Circular
RNA: A novel biomarker and therapeutic target for human cancers.
Int J Med Sci. 16:292–301. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P
and Wu M: CircRNA: Functions and properties of a novel potential
biomarker for cancer. Mol Cancer. 16:942017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aufiero S, Reckman YJ, Pinto YM and
Creemers EE: Circular RNAs open a new chapter in cardiovascular
biology. Nat Rev Cardiol. 16:503–514. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kong D, Piao YS, Yamashita S, Oshima H,
Oguma K, Fushida S, Fujimura T, Minamoto T, Seno H, Yamada Y, et
al: Inflammation-induced repression of tumor suppressor miR-7 in
gastric tumor cells. Oncogene. 31:3949–3960. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu S, Zhang P, Chen Z, Liu M, Li X and
Tang H: MicroRNA-7 downregulates XIAP expression to suppress cell
growth and promote apoptosis in cervical cancer cells. FEBS Lett.
587:2247–2253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang H, Cai K, Wang J, Wang X, Cheng K,
Shi F, Jiang L, Zhang Y and Dou J: MiR-7, inhibited indirectly by
lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of
breast cancer stem cells by downregulating the STAT3 pathway. Stem
Cells. 32:2858–2868. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok
MT, Wang H, Chen J, Ng SS, Chen M, et al: microRNA-7 is a novel
inhibitor of YY1 contributing to colorectal tumorigenesis.
Oncogene. 32:5078–5088. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Zheng F, Xiao X, Xie F, Tao D, Huang
C, Liu D, Wang M, Wang L, Zeng F and Jiang G: CircHIPK3 sponges
miR-558 to suppress heparanase expression in bladder cancer cells.
EMBO Rep. 18:1646–1659. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiao-Long M, Kun-Peng Z and Chun-Lin Z:
Circular RNA circ_HIPK3 is down-regulated and suppresses cell
proliferation, migration and invasion in osteosarcoma. J Cancer.
9:1856–1862. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu H, Chen Y and Jiang P: Circular RNA
HIPK3 exerts oncogenic properties through suppression of miR-124 in
lung cancer. Biochem Biophys Res Commun. 506:455–462. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kai D, Yannian L, Yitian C, Dinghao G, Xin
Z and Wu J: Circular RNA HIPK3 promotes gallbladder cancer cell
growth by sponging microRNA-124. Biochem Biophys Res Commun.
503:863–869. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Du WW, Yang W, Liu E, Yang Z, Dhaliwal P
and Yang BB: Foxo3 circular RNA retards cell cycle progression via
forming ternary complexes with p21 and CDK2. Nucleic Acids Res.
44:2846–2858. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Du WW, Fang L, Yang W, Wu N, Awan FM, Yang
Z and Yang BB: Induction of tumor apoptosis through a circular RNA
enhancing Foxo3 activity. Cell Death Differ. 24:357–370. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ashwal-Fluss R, Meyer M, Pamudurti NR,
Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and
Kadener S: circRNA biogenesis competes with pre-mRNA splicing.
Molecular Cell. 56:55–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang Q, Du WW, Wu N, Yang W, Awan FM, Fang
L, Ma J, Li X, Zeng Y, Yang Z, et al: A circular RNA promotes
tumorigenesis by inducing c-myc nuclear translocation. Cell Death
Differ. 24:1609–1620. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen N, Zhao G, Yan X, Lv Z, Yin H, Zhang
S, Song W, Li X, Li L, Du Z, et al: A novel FLI1 exonic circular
RNA promotes metastasis in breast cancer by coordinately regulating
TET1 and DNMT1. Genome Biol. 19:2182018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen CY and Sarnow P: Initiation of
protein synthesis by the eukaryotic translational apparatus on
circular RNAs. Science. 268:415–417. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Legnini I, Di Timoteo G, Rossi F, Morlando
M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade
M, et al: Circ-ZNF609 is a circular RNA that can be translated and
functions in myogenesis. Molecular Cell. 66:22–37.e9. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang Y, Gao X, Zhang M, Yan S, Sun C, Xiao
F, Huang N, Yang X, Zhao K, Zhou H, et al: Novel role of FBXW7
circular RNA in repressing glioma tumorigenesis. J Natl Cancer
Inst. 110:304–315. 2018. View Article : Google Scholar
|
|
34
|
Zhang M, Huang N, Yang X, Luo J, Yan S,
Xiao F, Chen W, Gao X, Zhao K, Zhou H, et al: A novel protein
encoded by the circular form of the SHPRH gene suppresses glioma
tumorigenesis. Oncogene. 37:1805–1814. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang S and Batur P: Human papillomavirus
in 2019: An update on cervical cancer prevention and screening
guidelines. Cleve Clin J Med. 86:173–178. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yee GP, de Souza P and Khachigian LM:
Current and potential treatments for cervical cancer. Curr Cancer
Drug Targets. 13:205–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mezei AK, Armstrong HL, Pedersen HN,
Campos NG, Mitchell SM, Sekikubo M, Byamugisha JK, Kim JJ, Bryan S
and Ogilvie GS: Cost-effectiveness of cervical cancer screening
methods in low- and middle-income countries: A systematic review.
Int J Cancer. 141:437–446. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Salzman J, Chen RE, Olsen MN, Wang PL and
Brown PO: Cell-type specific features of circular RNA expression.
PLoS Genet. 9:e10037772013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Han YN, Xia SQ, Zhang YY, Zheng JH and Li
W: Circular RNAs: A novel type of biomarker and genetic tools in
cancer. Oncotarget. 8:64551–64563. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zheng SR, Zhang HR, Zhang ZF, Lai SY,
Huang LJ, Liu J, Bai X, Ding K and Zhou JY: Human papillomavirus 16
E7 oncoprotein alters the expression profiles of circular RNAs in
Caski cells. J Cancer. 9:3755–3764. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gao YL, Zhang MY, Xu B, Han LJ, Lan SF,
Chen J, Dong YJ and Cao LL: Circular RNA expression profiles reveal
that hsa_circ_0018289 is up-regulated in cervical cancer and
promotes the tumorigenesis. Oncotarget. 8:86625–86633. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jiao J, Zhang T, Jiao X, Huang T, Zhao L,
Ma D and Cui B: hsa_circ_0000745 promotes cervical cancer by
increasing cell proliferation, migration, and invasion. J Cell
Physiol. 235:1287–1295. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang Y, Wang L, Wang W and Guo X:
Overexpression of circular RNA hsa_circ_0001038 promotes cervical
cancer cell progression by acting as a ceRNA for miR-337-3p to
regulate cyclin-M3 and metastasis-associated in colon cancer 1
expression. Gene. 733:1442732019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen RX, Liu HL, Yang LL, Kang FH, Xin LP,
Huang LR, Guo QF and Wang YL: Circular RNA circRNA_0000285 promotes
cervical cancer development by regulating FUS. Eur Rev Med
Pharmacol Sci. 23:8771–8778. 2019.PubMed/NCBI
|
|
48
|
Hu C, Wang Y, Li A, Zhang J, Xue F and Zhu
L: Overexpressed circ_0067934 acts as an oncogene to facilitate
cervical cancer progression via the miR-545/EIF3C axis. J Cell
Physiol. 234:9225–9232. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ding L and Zhang H: Circ-ATP8A2 promotes
cell proliferation and invasion as a ceRNA to target EGFR by
sponging miR-433 in cervical cancer. Gene. 705:103–108. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ma H, Tian T, Liu X, Xia M, Chen C, Mai L,
Xie S and Yu L: Upregulated circ_0005576 facilitates cervical
cancer progression via the miR-153/KIF20A axis. Biomed
Pharmacother. 118:1093112019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jiao J, Jiao X, Liu Q, Qu W, Ma D, Zhang Y
and Cui B: The Regulatory Role of circRNA_101308 in cervical cancer
and the prediction of its mechanism. Cancer Manag Res.
12:4807–4815. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ji F, Du R, Chen T, Zhang M, Zhu Y, Luo X
and Ding Y: Circular RNA circSLC26A4 accelerates cervical cancer
progression via miR-1287-5p/HOXA7 axis. Mol Ther Nucleic Acids.
19:413–420. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
He J, Lv X and Zeng Z: A potential disease
monitoring and prognostic biomarker in cervical cancer patients:
The clinical application of circular RNA_0018289. J Clin Lab Anal.
34:e233402020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang J, Zhao X, Zhang J, Zheng X and Li
F: Circular RNA hsa_circ_0023404 exerts an oncogenic role in
cervical cancer through regulating miR-136/TFCP2/YAP pathway.
Biochem Biophys Res Commun. 501:428–433. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tang Q, Chen Z, Zhao L and Xu H: Circular
RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical
cancer progression through up-regulation of ELK1. Aging (Albany
NY). 11:9982–9999. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu H, Wu Y, Wang S, Jiang J, Zhang C,
Jiang Y, Wang X, Hong L and Huang H: Circ-SMARCA5 suppresses
progression of multiple myeloma by targeting miR-767-5p. BMC
Cancer. 19:9372019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Dong C, Fan B, Ren Z, Liu B and Wang Y:
CircSMARCA5 facilitates the progression of prostate cancer through
miR-432/PDCD10 axis. Cancer Biother Radiopharm. 2020.(Online ahead
of print). View Article : Google Scholar
|
|
58
|
Tian JDC and Liang L: Involvement of
circular RNA SMARCA5/microRNA-620 axis in the regulation of
cervical cancer cell proliferation, invasion and migration. Eur Rev
Med Pharmacol Sci. 22:8589–8598. 2018.PubMed/NCBI
|
|
59
|
Yang C, Yuan W, Yang X, Li P, Wang J, Han
J, Tao J, Li P, Yang H, Lv Q and Zhang W: Circular RNA circ-ITCH
inhibits bladder cancer progression by sponging miR-17/miR-224 and
regulating p21, PTEN expression. Mol Cancer. 17:192018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang ST, Liu LB, Li XM, Wang YF, Xie PJ,
Li Q, Wang R, Wei Q, Kang YH, Meng R and Feng XH: Circ-ITCH
regulates triple-negative breast cancer progression through the
Wnt/β-catenin pathway. Neoplasma. 66:232–239. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Li J, Guo R, Liu Q, Sun J and Wang H:
Circular RNA Circ-ITCH inhibits the malignant behaviors of cervical
cancer by microRNA-93-5p/FOXK2 Axis. Reprod Sci. 27:860–868. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cai H, Zhang P, Xu M, Yan L, Liu N and Wu
X: Circular RNA hsa_circ_0000263 participates in cervical cancer
development by regulating target gene of miR-150-5p. J Cell
Physiol. 234:11391–11400. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Torre LA, Trabert B, DeSantis CE, Miller
KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A and Siegel RL:
Ovarian cancer statistics, 2018. CA Cancer J Clin. 68:284–296.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Hackshaw A, Gershenson D and Ledermann J:
Mucinous Ovarian Carcinoma. N Engl J Med. 381:e32019. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang L, Wang Q, Xu Y and Han L: Advances
in the treatment of ovarian cancer using PARP inhibitors and the
underlying mechanism of resistance. Current Drug Targets.
21:167–178. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Hansen JM, Coleman RL and Sood AK:
Targeting the tumour microenvironment in ovarian cancer. Eur J
Cancer. 56:131–143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Teng F, Xu J, Zhang M, Liu S, Gu Y, Zhang
M, Wang X, Ni J, Qian B, Shen R and Jia X: Comprehensive circular
RNA expression profiles and the tumor-suppressive function of
circHIPK3 in ovarian cancer. Int J Biochem Cell Biol. 112:8–17.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ning L, Long B, Zhang W, Yu M, Wang S, Cao
D, Yang J, Shen K, Huang Y and Lang J: Circular RNA profiling
reveals circEXOC6B and circN4BP2L2 as novel prognostic biomarkers
in epithelial ovarian cancer. Int J Oncol. 53:2637–2646.
2018.PubMed/NCBI
|
|
69
|
Gao Y, Zhang C, Liu Y and Wang M: Circular
RNA profiling reveals circRNA1656 as a novel biomarker in high
grade serous ovarian cancer. Biosci Trends. 13:204–211. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Fan CM, Wang JP, Tang YY, Zhao J, He SY,
Xiong F, Guo C, Xiang B, Zhou M, Li XL, et al: circMAN1A2 could
serve as a novel serum biomarker for malignant tumors. Cancer Sci.
110:2180–2188. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Pei C, Wang H, Shi C, Zhang C and Wang M:
CircRNA hsa_circ_0013958 may contribute to the development of
ovarian cancer by affecting epithelial-mesenchymal transition and
apoptotic signaling pathways. J Clin Lab Anal. 34:e232922020.
View Article : Google Scholar
|
|
72
|
Zou T, Wang PL, Gao Y and Liang WT:
Circular RNA_LARP4 is lower expressed and serves as a potential
biomarker of ovarian cancer prognosis. Eur Rev Med Pharmacol Sci.
22:7178–7182. 2018.PubMed/NCBI
|
|
73
|
Zhao Y, Hu Y, Shen Q, Chen Q, Zhu XJ,
Jiang SS and Zhang Q: CircRNA_MYLK promotes malignant progression
of ovarian cancer through regulating microRNA-652. Eur Rev Med
Pharmacol Sci. 24:5281–5291. 2020.PubMed/NCBI
|
|
74
|
Zhang M, Xia B, Xu Y, Zhang Y, Xu J and
Lou G: Circular RNA (hsa_circ_0051240) promotes cell proliferation,
migration and invasion in ovarian cancer through miR-637/KLK4 axis.
Artif Cells Nanomed Biotechnol. 47:1224–1233. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Chen Y, Ye X, Xia X and Lin X: Circular
RNA ABCB10 correlates with advanced clinicopathological features
and unfavorable survival, and promotes cell proliferation while
reduces cell apoptosis in epithelial ovarian cancer. J Nurs
Scholarsh. 26:151–161. 2019.
|
|
76
|
Zhao Y, Qin XP, Lang YP, Kou D and Shao
ZW: Circular RNA circ-SMAD7 promoted ovarian cancer cell
proliferation and metastasis by suppressing KLF6. Eur Rev Med
Pharmacol Sci. 23:5603–5610. 2019.PubMed/NCBI
|
|
77
|
Bao L, Zhong J and Pang L: Upregulation of
Circular RNA VPS13C-has-circ-001567 promotes ovarian cancer cell
proliferation and invasion. Cancer Biother Radiopharm. 34:110–118.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Chen H, Mao M, Jiang J, Zhu D and Li P:
Circular RNA CDR1as acts as a sponge of miR-135b-5p to suppress
ovarian cancer progression. Onco Targets Ther. 12:3869–3879. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang N, Jin Y, Hu Q, Cheng S, Wang C,
Yang Z and Wang Y: Circular RNA hsa_circ_0078607 suppresses ovarian
cancer progression by regulating miR-518a-5p/Fas signaling pathway.
J Ovarian Res. 13:642020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Li X, Lin S, Mo Z, Jiang J, Tang H, Wu C
and Song J: CircRNA_100395 inhibits cell proliferation and
metastasis in ovarian cancer via regulating
miR-1228/p53/epithelial-mesenchymal transition (EMT) axis. J
Cancer. 11:599–609. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wang W, Wang J, Zhang X and Liu G: Serum
circSETDB1 is a promising biomarker for predicting response to
platinum-taxane-combined chemotherapy and relapse in high-grade
serous ovarian cancer. Onco Targets Ther. 12:7451–7457. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Zhao Z, Ji M, Wang Q, He N and Li Y:
Circular RNA Cdr1as upregulates SCAI to suppress cisplatin
resistance in ovarian cancer via miR-1270 suppression. Mol Ther
Nucleic Acids. 18:24–33. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Lortet-Tieulent J, Ferlay J, Bray F and
Jemal A: International patterns and trends in endometrial cancer
incidence, 1978–2013. J Natl Cancer Inst. 110:354–361. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
McAlpine JN, Temkin SM and Mackay HJ:
Endometrial cancer: Not your grandmother's cancer. Cancer.
122:2787–2798. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Braun MM, Overbeek-Wager EA and Grumbo RJ:
Diagnosis and management of endometrial cancer. Am Fam Physician.
93:468–474. 2016.PubMed/NCBI
|
|
86
|
Moore K and Brewer MA: Endometrial cancer:
Is this a new disease? Am Soc Clin Oncol Educ Book. 37:435–442.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Urick ME and Bell DW: Clinical
actionability of molecular targets in endometrial cancer. Nat Rev
Cancer. 19:510–521. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Bokhman JV: Two pathogenetic types of
endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Suarez AA, Felix AS and Cohn DE: Bokhman
Redux: Endometrial cancer ‘types’ in the 21st century. Gynecol
Oncol. 144:243–249. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Cancer Genome Atlas Research Network, .
Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H,
Robertson AG, Pashtan I, Shen R, et al: Integrated genomic
characterization of endometrial carcinoma. Nature. 497:67–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Colombo N, Creutzberg C, Amant F, Bosse T,
González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza
MR, et al: ESMO-ESGO-ESTRO Consensus Conference on Endometrial
Cancer: diagnosis, treatment and follow-up. Ann Oncol. 27:16–41.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Ye F, Tang QL, Ma F, Cai L, Chen M, Ran
XX, Wang XY and Jiang XF: Analysis of the circular RNA
transcriptome in the grade 3 endometrial cancer. Cancer Manag Res.
11:6215–6227. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Xu H, Gong Z, Shen Y, Fang Y and Zhong S:
Circular RNA expression in extracellular vesicles isolated from
serum of patients with endometrial cancer. Epigenomics. 10:187–197.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Chen BJ, Byrne FL, Takenaka K, Modesitt
SC, Olzomer EM, Mills JD, Farrell R, Hoehn KL and Janitz M:
Analysis of the circular RNA transcriptome in endometrial cancer.
Oncotarget. 9:5786–5796. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Wang H, Douglas W, Lia M, Edelmann W,
Kucherlapati R, Podsypanina K, Parsons R and Ellenson LH: DNA
mismatch repair deficiency accelerates endometrial tumorigenesis in
Pten heterozygous mice. Am J Pathol. 160:1481–1486. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Stambolic V, Tsao MS, Macpherson D, Suzuki
A, Chapman WB and Mak TW: High incidence of breast and endometrial
neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer
Res. 60:3605–3611. 2000.PubMed/NCBI
|
|
97
|
Liu Y, Chen S, Zong ZH, Guan X and Zhao Y:
CircRNA WHSC1 targets the miR-646/NPM1 pathway to promote the
development of endometrial cancer. J Cell Mol Med. 24:6898–6907.
2020. View Article : Google Scholar : PubMed/NCBI
|
